戻る Agenda
RISK-BASED APPROACHES TO ENSURE DATA INTEGRITY
Session Chair(s)
Peter Schiemann, PHD, MBA
Managing Partner
Widler & Schiemann Ltd, Switzerland
Learning Objective : The audience will learn about the relationship between eDM and data quality and how the two are linked to the RbM (Risk-based Monitoring) approach that is currently favoured by many. The Audience will learn what elements to take into consideration and how to prioritise system development and tasks when planning and building a risk based approach to managing clinical trials.
Speaker(s)
eDM as Foundation for Managing Clinical Trials
Peter Schiemann, PHD, MBA
Widler & Schiemann Ltd, Switzerland
Managing Partner
ACRES
Greg Koski, MD, PHD
Alliance For Clinical Research Excellence and Safety (ACRES), United States
President and CEO, Co-Founder